..looking goooooood!! LOL
3:41 PM ET Aug 24, 2000:
Thursday, August 24, 2000
INCR gets stem cell boost
--3:41 pm - By Michael Baron
In what feels like an eerie replay of the frenzied buying in biotechnology stocks earlier this year, Incara Pharmaceuticals (INCR: news, msgs) is being bid up Thursday because of its involvment with stem cell research. After driving up StemCells (STEM: news, msgs) and Aastrom BioSciences (ASTM: news, msgs) Wednesday and again today [see 10:13 am item], investors are scooping up shares of other lesser known companies that could benefit from the repeal of a ban on federal funding of research on embryotic stem cells. Incara, which is developing a liver precursor cell therapy to treat liver failure, is soaring 1 5/16, or 48.8 percent, to 4, on volume of 521,000 shares. Average daily volume is 178,100. |
